(Q34228103)

English

Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies (English)

1 reference

Europe PubMed Central

31 July 2017

anti-retroviral agent

0 references

18

object named as

M E Egger

1 reference

Europe PubMed Central

31 July 2017

Dominique Costagliola

4

object named as

D Costagliola

1 reference

Europe PubMed Central

31 July 2017

8

object named as

J Lundgren

1 reference

Europe PubMed Central

31 July 2017

Geneviève Chêne

1

object named as

G Chêne

1 reference

Europe PubMed Central

31 July 2017

11

object named as

R Hogg

1 reference

Europe PubMed Central

31 July 2017

François Dabis

7

object named as

F Dabis

1 reference

Europe PubMed Central

31 July 2017

Jonathan Sterne

2

object named as

J A C Sterne

1 reference

Europe PubMed Central

31 July 2017

Antonella d'Arminio Monforte

9

object named as

A D'Arminio Monforte

1 reference

Europe PubMed Central

31 July 2017

12

object named as

P Reiss

1 reference

Europe PubMed Central

31 July 2017

author name string

M May

3

1 reference

Europe PubMed Central

31 July 2017

B Ledergerber

5

1 reference

Europe PubMed Central

31 July 2017

A N Phillips

6

1 reference

Europe PubMed Central

31 July 2017

F de Wolf

10

1 reference

Europe PubMed Central

31 July 2017

A Justice

13

1 reference

Europe PubMed Central

31 July 2017

C Leport

14

1 reference

Europe PubMed Central

31 July 2017

S Staszewski

15

1 reference

Europe PubMed Central

31 July 2017

J Gill

16

1 reference

Europe PubMed Central

31 July 2017

G Fatkenheuer

17

1 reference

Europe PubMed Central

31 July 2017

Antiretroviral Therapy Cohort Collaboration

19

1 reference

Europe PubMed Central

31 July 2017

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

362

1 reference

Europe PubMed Central

31 July 2017

9385

1 reference

Europe PubMed Central

31 July 2017

679-686

1 reference

Europe PubMed Central

31 July 2017

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: the Aquitaine Cohort, 1996-1997

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population. Royal Free Centre for HIV Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4 cell counts at the third month of HAART may predict clinical failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Zidovudine and stavudine sequencing in HIV treatment planning: findings from the CHORUS HIV cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The antiviral effect of ritonavir and saquinavir in combination amongst HIV-infected adults: results from a community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997. Royal Free Centre for HIV Medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of a viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Fetal origins of adult disease-the hypothesis revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A new look at the statistical model identification

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Bayesian measures of model complexity and fit

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors Associated with Mortality in Human Immunodeficiency Virus Type 1–Infected Adults Initiating Protease Inhibitor–Containing Therapy: Role of Education Level and of Early Transaminase Level Elevation (APROCO–ANRS EP11 Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A Clinically Prognostic Scoring System for Patients Receiving Highly Active Antiretroviral Therapy: Results from the EuroSIDA Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial virological and immunologic response to highly active antiretroviral therapy predicts long-term clinical outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2914229-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(03)14229-8

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34228103&oldid=1751775410"